These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

829 related items for PubMed ID: 21695188

  • 1. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [Abstract] [Full Text] [Related]

  • 2. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG, Mele V, Däster S, Han J, Heberer M, Cesare Spagnoli G, Iezzi G.
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [Abstract] [Full Text] [Related]

  • 3. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY.
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N.
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [Abstract] [Full Text] [Related]

  • 5. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ.
    Cancer Res; 2011 Jun 01; 71(11):3991-4001. PubMed ID: 21498635
    [Abstract] [Full Text] [Related]

  • 6. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R.
    Stem Cells; 2009 Dec 01; 27(12):2875-83. PubMed ID: 19816957
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
    Lin L, Hutzen B, Lee HF, Peng Z, Wang W, Zhao C, Lin HJ, Sun D, Li PK, Li C, Korkaya H, Wicha MS, Lin J.
    PLoS One; 2013 Dec 01; 8(12):e82821. PubMed ID: 24376586
    [Abstract] [Full Text] [Related]

  • 8. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W.
    Int J Cancer; 2012 Jan 01; 130(1):29-39. PubMed ID: 21480217
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ, Beardsley BE, Harris GC, Gunningham SP, Dachs GU, Dijkstra B, Morrin HR, Wells JE, Robinson BA.
    Hum Pathol; 2013 Mar 01; 44(3):402-11. PubMed ID: 23036368
    [Abstract] [Full Text] [Related]

  • 10. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.
    Jimeno A, Feldmann G, Suárez-Gauthier A, Rasheed Z, Solomon A, Zou GM, Rubio-Viqueira B, García-García E, López-Ríos F, Matsui W, Maitra A, Hidalgo M.
    Mol Cancer Ther; 2009 Feb 01; 8(2):310-4. PubMed ID: 19174553
    [Abstract] [Full Text] [Related]

  • 11. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W.
    Pathol Int; 2012 Feb 01; 62(2):112-9. PubMed ID: 22243781
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, Ali S, Li Y, Kong D, Banerjee S, Back J, Sarkar FH.
    J Biol Chem; 2014 May 23; 289(21):14520-33. PubMed ID: 24719318
    [Abstract] [Full Text] [Related]

  • 13. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L, Huang X, Zheng X, Wang X, Li S, Zhang L, Yang Z, Xia Z.
    Int J Biol Sci; 2013 May 23; 9(5):472-9. PubMed ID: 23781140
    [Abstract] [Full Text] [Related]

  • 14. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.
    J Natl Cancer Inst; 2010 Nov 03; 102(21):1637-52. PubMed ID: 20935265
    [Abstract] [Full Text] [Related]

  • 15. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G, Nardone G.
    J Cell Physiol; 2012 Jun 03; 227(6):2686-93. PubMed ID: 21898409
    [Abstract] [Full Text] [Related]

  • 16. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
    Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J.
    Cancer Res; 2011 Dec 01; 71(23):7226-37. PubMed ID: 21900397
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
    Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, Matsuno Y, Taketomi A.
    BMC Cancer; 2014 Sep 21; 14():687. PubMed ID: 25240521
    [Abstract] [Full Text] [Related]

  • 18. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.
    Cancer Genomics Proteomics; 2009 Sep 21; 6(1):19-29. PubMed ID: 19451087
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
    Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, Goggins M, Iacobuzio-Donahue C, Berman DM, Laheru D, Jimeno A, Hidalgo M, Maitra A, Matsui W.
    J Natl Cancer Inst; 2010 Mar 03; 102(5):340-51. PubMed ID: 20164446
    [Abstract] [Full Text] [Related]

  • 20. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.
    Int J Oncol; 2013 Aug 03; 43(2):425-30. PubMed ID: 23708747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.